Cargando…

Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic

Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dassarma, Barsha, Tripathy, Satyajit, Matsabisa, Motlalepula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718590/
https://www.ncbi.nlm.nih.gov/pubmed/33285298
http://dx.doi.org/10.1016/j.tracli.2020.11.004
_version_ 1783619518931664896
author Dassarma, Barsha
Tripathy, Satyajit
Matsabisa, Motlalepula
author_facet Dassarma, Barsha
Tripathy, Satyajit
Matsabisa, Motlalepula
author_sort Dassarma, Barsha
collection PubMed
description Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of preventive as well as therapeutic options for treating and managing the infection. The use of ancient immunotherapeutic technique – the convalescent plasma (CP) therapy, may act as an immediate and available option to control the COVID-19 pandemic. This review provides a concept and understanding on the CP therapy, its potential to control SARS-CoV-2 pandemic. The CP therapy might act as an immediate saviour for society from the virus. Although the CP therapy has exert affirmative result against COVID-19 it has not been recommended for long time use in COVID-19 and this review gives support for its possible application.
format Online
Article
Text
id pubmed-7718590
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS).
record_format MEDLINE/PubMed
spelling pubmed-77185902020-12-07 Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic Dassarma, Barsha Tripathy, Satyajit Matsabisa, Motlalepula Transfus Clin Biol Review Article Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of preventive as well as therapeutic options for treating and managing the infection. The use of ancient immunotherapeutic technique – the convalescent plasma (CP) therapy, may act as an immediate and available option to control the COVID-19 pandemic. This review provides a concept and understanding on the CP therapy, its potential to control SARS-CoV-2 pandemic. The CP therapy might act as an immediate saviour for society from the virus. Although the CP therapy has exert affirmative result against COVID-19 it has not been recommended for long time use in COVID-19 and this review gives support for its possible application. Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). 2021-02 2020-12-05 /pmc/articles/PMC7718590/ /pubmed/33285298 http://dx.doi.org/10.1016/j.tracli.2020.11.004 Text en © 2020 Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Dassarma, Barsha
Tripathy, Satyajit
Matsabisa, Motlalepula
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
title Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
title_full Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
title_fullStr Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
title_full_unstemmed Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
title_short Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
title_sort emergence of ancient convalescent plasma (cp) therapy: to manage covid-19 pandemic
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718590/
https://www.ncbi.nlm.nih.gov/pubmed/33285298
http://dx.doi.org/10.1016/j.tracli.2020.11.004
work_keys_str_mv AT dassarmabarsha emergenceofancientconvalescentplasmacptherapytomanagecovid19pandemic
AT tripathysatyajit emergenceofancientconvalescentplasmacptherapytomanagecovid19pandemic
AT matsabisamotlalepula emergenceofancientconvalescentplasmacptherapytomanagecovid19pandemic